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Summary.-The synthesis and localization of collagen have been studied on material
from a total of 16 primary Ewing's tumours. The predominant collagen extracted
from the tissues and synthesized in short-term cultures was type I. The proportion
of type III collagen was relatively small and variable (0-8%) in the direct tumour
extracts, but a higher proportion (29-38% of the total collagens) was synthesized in
culture. Immunofluorescence studies showed that positive staining for all types of
collagen tested (types I, III, IV and V) was restricted to stroma; there was no evidence
of collagen either within the tumour cells or in their pericellular matrix, a finding
endorsed by negative staining for reticulin in the same areas. The absence of any
evidence for type IV or V collagen synthesis by Ewing's cells argues against an
endothelial origin for the tumour, and indicates that collagen analysis is unlikely to
be of value in the diagnosis of this particular sarcoma.
DURING THE LAST DECADE, 5 genetically
distinct collagens, designated types I-V,
have been recognized. Their molecular
form and characteristic tissue distribution
are summarized in the Table. The individ-
ual collagen types can now be identified by
both biochemical and immunological tech-
niques, and this has led to a greater
understanding of the pathology of such
diseases as the inherited defects ofcollagen
synthesis (Prockop et al., 1979).
The so-called "small round-cell tum-
ours" of bone or of soft tissue are a
frequent source of diagnostic difficulty to
histopathologists. Sometimes conventional
histopathological techniques fail to dis-
tinguish Ewing's sarcoma from metastatic
neuroblastoma, rhabdomyosarcoma, so-
called "reticulum-cell sarcoma" and,
occasionally, small-cell osteogenic sarcoma
(Ball et al., 1977). In addition, the
histogenesis of Ewing's sarcoma is still a
source of contention. Ewing himself
(Ewing, 1921) considered that the tumour
cells were derived from endothelium, but
others have suggested an origin from a
bone-marrow stem cell (Kadin & Bensch,
1971).
Since immunological investigation of
collagen in osteogenic sarcoma revealed
that malignant osteoblasts retained the
collagen phenotype of normal osteoblasts,
i.e.synthesized type Icollagen (Remberger
& Gay, 1977), we set out to determine if
analysis of collagen in Ewing's sarcoma
would yield information relevant to the
diagnosis or histogenetic origin of the
tumour. To do this we used biochemical
and immunofluorescence methods to
identify and localize collagen in frozen
tissue and short-term cultures from
Ewing's tumours.
METHODS AND MATERIALS
Tumour material.-Tissue was obtained
from primary tumours of 16 patients, of
whom 12 had had no prior treatment and 3
had received pulsed chemotherapy (2, 4 or 6COLLAGEN IN EWING'S TUMOUR
TABLE.-The composition and tissue distribution of the genetically distinct collagens
Molecular Chain
Type types types










actinomycin D, adriamycin or cyclophos- I
phamide) before surgery. The primary tum- I
our sites comprised: pelvis (4 cases), rib (7),
tibia (1), humerus (1), vertebrae (1), media- I
stinum (1) and femur (1). In each case the
diagnosis of Ewing's tumour was made on ;
examination ofwax-embedded sections.
Collagens in tumour specimens were exam- I
ined by one or more ofthe following methods: i
indirect immunofluorescence (11 specimens), i
electrophoresis of extracted and purified i
collagens (5 specimens), and electrophoretic
and chromatographic separation of collagens i
synthesized in short-term culture (3 speci- I
mens). In addition, wax-embedded sections of I
the tumours were stained for reticulin
(Gordon Sweet stain). I
Tissue for immunofluoresence studies and I
collagen extraction was snap-frozen and
stored at -20°C until use. Tissue for culture I
studies was transported in Hanks' balanced
saltsolution (HBSS).
Tissue culture.-Tissue-culture materials
were obtained from Gibco-Europe. Tumour
tissue was chopped into fragments approxi-
mately 1 mm3, washed in HBSS, andportions
of approximately 100 mg (wet wt) were
placed in 25cm2 culture flasks containing 5 ml
Dulbecco's Modified Eagle's Medium supple-
mented with foetal calfserum (10%), penicil-
lin and streptomycin (100 u/ml each), and
glutamine (2 mM), buffered with bicarbonate
in a humidified atmosphere of 5% C02/95%
air. Collagen synthesized in these cultures was
radioactively labelled by the addition ofL-(5-
3H) proline (50 ,Ci/ml, 23 mCi/mMol-Amer-
sham International), plus ascorbate (50 ,tg/
ml) and (/3-aminopropionitrile fumarate (50
Tissue distribution
Bone, tendon, dermis
dentin, synovium and most
stroma
Hyaline cartilage and
nucleus pulposus of inter-
vertebral disc
Synovium, arteries, dermis,
uterus and most stroma
Basement membranes
Pericellular
,ug/ml) to inhibit aldehyde-derived cross-
linking of the collagen, for a total culture
period of 24 h.
Collagen analysis.-Collagens were extrac-
ted directly from the tissues, or from the
cultured tissues combined with their media
and 100 ,ug ofacid-soluble rat skin collagen as
carrier, by homogenization in 0-5M acetic acid
at4°C, followed bypepsindigestion (1 mg/ml)
for 24 h. Insoluble material was resuspended
in fresh acetic acid and pepsin, digested for a
further24 handcentrifuged. Thesupernatant
was added to the first extract, and any
remaining insoluble material was hydrolysed
at 1100C in 6N 1I1 for 16 h and analysed for
hydroxyproline using an automated colori-
metric assay (Bannister & Burns, 1970).
Collagens were purified by precipitating twice
from acidic solution by addition of1-6M NaCl,
then dialysed against 0-5M acetic acid and
lyophilized.
Identification of radioactively-labelled col-
lagens by carboxymethyl cellulose (CMC)
chromatography was performed as described
previously (Webster & Harvey, 1979).
Approximately 80,000 dpm of each 3H-
labelled collagen sample was dissolved with
2 mg of carrier acid-soluble rat-skin collagen
in 0-06M acetate buffer, pH 4-8, containing IM
urea, and applied to a 6-0 x 1 5cm column of
CM 52 (Whatman) maintained at 450C.
Collagens were eluted with an increasing
gradient of0-015M NaCl over a total volume
of 200 ml. Fractions (1.6 ml) were collected
and radioactivity measured after addition of
3-0 ml scintillant (Unisolve 1, Koch-Light).
Radioactively-labelled collagens were also
analysed by sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS PAGE)
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using rod gels (10 x 0u5 cm, 5% acrylamide,
0.05% bis-acrylamide in 80mM tris-borate
buffer, pH 8.6). Samples of 70,000 dpm
were dissolved in the above buffer containing
IM urea, 2% glycerol and a trace of
bromophenol blue as marker dye. Electro-
phoresis was performed inthe buffer described
above at 1 mamp/gel and the gels were
subsequently sliced into 1mm-thick discs
before alkaline hydrolysis and measurement
ofradioactivity (Webster & Harvey, 1979).
Analysis ofcollagens extracted from native
tumour tissue was performed by SDS PAGE
with slab gels (14 x 16 x 0415 cm) using acryl-
amide and buffer as described above. Collagen
samples were dissolved at 2 mg/ml in sample
buffer and duplicate 20,u1 samples were loaded
into adjacent lcm wells and electrophoresed
at 20 mamp/gel. Separation of type III
collagen chains from type I was achieved by a
delayed-reduction technique (Sykes et at.,
1976): after 20 min the electrophoresis was
stopped and 20 tl of a 20% (v/v) solution of
2-mercaptoethanol in sample buffer was
added to one ofeach pair ofsample wells (Fig.
1, tracks 2 and 4), and allowed to diffuse into
the gel for 30 min before electrophoresis was
restarted. This procedure reduces disulphide
bonds and causes the cx chains of type III
collagen to migrate at the same speed as, but
behind, the xl chains of type I collagen. The
gels were fixed and stained in a 0-15%
solution of Coomassie blue R 250 in 12°,
trichloracetic acid, and destained in 7.50/a
acetic acid. Each track was then scanned in a
Joyce-Loebl 200 densitometer with a lcm slit
length and a 570-580 nm filter. The collagen
bands were quantitated by planimetry, and
the proportion oftype III collagen expressed
as apercentage ofthe total.
Immunofluorescence studies.-Serial cryo-
stat sections (3-4 ,um) were stainedforeach of
the 4 collagen types under study, and also
with haematoxylin and eosin. Type-specific
antisera to human collagen types I and III
were raised in goats, and antisera to types IV
and V in rabbits. Details of the preparations
and specificity of antisera to types I, III and
IV collagens are described by Duance et al.
(1977), and antiserum to type V collagen by
Bailey et al. (1979).
To identify type I and type III collagen,
sections were pre-incubated in a 1:10 dilution
of normal rabbit serum and then exposed to
goat anti-collagen antibodies at a dilution of
1:100 for 12-18 h at 4°C. The sections were
then washed with phosphate-buffered saline
(PBS) and incubated with fluorescein-
conjugated rabbit anti-goat antibodies (Sera-
Lab) at a dilution of 1:20 for 2 h at 20°C. The
sections were washed in PBS, mounted in
glycerine jelly, and examined with a Zeiss
Universal microscope using epi-illumination
from a Zeiss 100 UV illuminator.
For identification of collagen types IV and
V the sections were treated as above except
for pre-incubation with pig serum, incubation
with rabbit anti-collagen antibodies and
staining with fluorescein-conjugated pig anti-
rabbit serum (Dako) at 1:20 dilution. Control
sections were incubated with normal goat
serumornormalrabbitserumat 1: 100dilution
in place ofthe anti-collagen antibodies.
RESULTS
The proportion of collagen in the
tumour tissues was high (30-50 mg/g wet
wt) and it was completely solubilized by
the limited pepsin digestion. In some
preparations a trace of insoluble residual
material was found after centrifugation of
the second pepsin digest. This material
contained no detectable hydroxyproline.
Electrophoresis showed that the extracted
collagen was predominantly type I (Fig.
1). The amounts of type III collagen
measured in the 5 preparations examined
FiG. 1. SDS polyacrylamide gel electro-
phoresis of collagen extracted from a
Ewing's tumour (tracks 3 & 4) compared
with a mixture of standard human skin
collagens types I and III (tracks 1 & 2).
Type III collagen co-migrating with the
cx chains and higher-mol.-wt components
(tracks 1 & 3) is revealed in tracks 2 and 4
following reduction of disulphide bonds
by addition of 2-mercaptoethanol 20 min
after the start of electrophoresis (see
Materials and Methods).
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FIG. 2.-Section ofEwing's tumourshowingislands oftumourcellsand dense fibrous stroma. H. & E. x 120 ses2ott>w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~..:!T-...
FIG. 3.-Ewing's tumour (adjacent section to that in Fig. 2) stained for reticulin (Gordon Sweet stain).
Staining has occurred predominantly in the connective tissue stroma. x 120.
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FIG. 5. CMC chromatography ofradioactively-
labelled collagen synthesized by Ewing's
tumour tissue in vitro. Elution positions
of standard human collagen chains (cAt(I),
Al(III) and a2(I)) are shown.
were: 0, 6, 3, 4, 4 and 80% of the total. A
typical preparation is shown in tracks 3
and 4 (Fig. 1) and compared with a
mixture of type I and type III collagen
standards in tracks 1 and 2. There were no
detectable type IV collagen chains in any
of these purified collagen samples.
Histological examination ofthe tumours
revealed islands of small round tumour
cells with very little intercellular matrix,
separated by varying amounts of vascular
connective tissue (Fig. 2). Sections stained
for reticulin showed heavy silver deposi-
tion in the connective-tissue stroma and
some blood vessels, but no staining of the
tumour cells or their intercellular matrix
(Fig. 3).
Antibodies to type I (Fig. 4a) collagen
and to type III collagen (Fig. 4b) produced
a similar pattern of intense fluorescent
staining, localized mainly in the dense
connective-tissue stroma, but occasionally
observed around small blood vessels
between the tumour cells. The tumour
cells and the matrix immediately around
the tumour cells were negative. Antibodies
to type IV (Fig. 4c) and type V collagen
(Fig. 4d) showed clear staining of base-
ment membranes around blood vessels and
some fibres in the adjacent connective
10 0 30 0 X
MJMATCNJ ()
FTG. 6.-SDS polyacrylamide gel electrophor-
esis of the same preparation described in
Fig. 6, with (---) and without ( )
prior reduction of the sample by denatur-
ation in the presence of 1000 (v/v) 2-mer-
captoethanol. Radioactivity in the posi-
tion of AIl(IIJ)3 migrated with oIl(I) chains
in the reduced sample.
tissue, but no staining in or around tumour
cells themselves. No distinct differences
between the localization oftypes IV and V
were identified in these preparations.
Collagen synthe8is in vitro
The tumour tissues synthesized collagen
during the 24h-culture period, and the
radioactively-labelled chains were identi-
fied by CMC chromatography (Fig. 5) and
SDS PAGE (Fig. 6) by their co-elution and
co-migration, respectively, with standard
collagens from rat skin or radioactively-
labelled human dermal fibroblast cultures.
Recovery of radioactive collagen from
CMC chromatography was consistently
>90%0, due to pre-treatment of the CMC
with an excess of rat-skin collagen
(Webster & Harvey, 1979).
The newly-synthesized collagen was
largely type I, with type III contributing
29-38% ofthe total. There was evidence of
type V collagen synthesis, demonstrated
by the small peak migrating in the position
of (xI(V) on SDS PAGE (Fig. 6). The
contribution of this peak was approxi-
mately 300 of the total. The ratio of
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radioactivity in the xl(I) peak to that in
the a2 peak calculated from chromato-
graphic and electrophoretic profiles ranged
from 2-3:1 to 3-4:1.
DISCUSSION
In this study we have found that the
collagen extracted from Ewing's tumours
was predominantly type I, with a small
and variable amount of type III. The
collagen synthesized by tumour tissues in
short-term cultures was also predomin-
antly type I, but the percentage of type
III collagen (29-38%) was markedly
higher than that extracted from the parent
tumour tissue. The relative rates of
synthesis or degradation of type I and
type III collagen were therefore altered
when the tissue was cultured. The ratio of
1z:A2 chains of radioactively-labelled
collagen was higher than the ratio of 2:1
expected for type I collagen. This may
have been due to unequal incorporation of
3H-proline into the cxl and Ao2 chains or
may reflect the synthesis of some type I
trimer (od(I)3).
Since histopathological examination of
all the tumours revealed considerable
infiltration by stromal fibroblasts cells
known to synthesize both type I and type
III collagen (Gay et al., 1976) it was
critical to determine the cellular origin of
the collagens found and synthesized in the
tumours. The immunofluorescence studies
(Fig. 4a-d) showed no collagen types I,
III, IV or V either in the tumour cells
themselves or in their extracellular matrix.
These collagens were apparently restricted
to the connective-tissue stroma and blood
vessels. The absence of type III collagen
from the tumour cell matrix in our
immunofluorescence studieswas supported
by the negative reticulin stain (Fig. 3).
Immunologically reactive type III colla-
gen has been described in a wide range of
bone and cartilage tumours (Remberger &
Gay, 1977), but the absence ofcytoplasmic
staining for type III collagen led these
authors to conclude that the accompany-
ing vascular stroma, rather than the
tumour cells themselves, were the sites of
type III collagen synthesis; our results
confirm this to be the case in Ewing's
sarcoma. The apparent formation of bone
in Ewing's tumour with positive immuno-
fluorescence to type I collagen reported by
Remberger & Gay (1977) could be
explained by the synthesis of reactive
osteoid derived from normal osteoblasts.
We have found no evidence for bone
formation by Ewing's tumour cells.
Ewing (1921) described the tumour
bearing his name as an "endothelial
myeloma." However, Ewing's tumours
lack the vascular elements and extra-
cellular material which are characteristic
of neoplasms of true angioblastic origin
such as hemangioendothelioma (Stout,
1943) or angiosarcoma recently described
by Bednar (1980). This has led others (e.g.
Kadin & Bensch, 1971) to reject the
concept of an endothelial origin and
postulate that Ewing's tumour is a
myelogenous neoplasm, possibly of multi-
focal origin. Our own findings do not
suggest a vascular origin of the tumour,
and contrast with a brief report of
immunofluorescent staining with anti-
bodies to type IV collagen in Ewing's
tumour (Roessner et al., 1980) and with a
report that a cell line derived from a
Ewing's tumour synthesized type I and
type III procollagens as well as fibronectin
(Stern et al., 1980). Cells of endothelial
origin would be expected to synthesize
type IV collagen-a characteristic base-
ment-membrane component and pos-
sibly type V in culture (Howard et al.,
1976; Madri et al., 1980), but endothelial
cells have also been reported to synthesize
type I and type III collagen in vitro
(Barnes et al., 1978). This diversity of
collagen phenotype between different
endothelial cell cultures emphasizes that
patterns of collagen synthesis by cells in
vitro should be interpreted with caution.
In conclusion, our studies indicate that
(i) biochemical and immunofluorescent
analysis of collagen is unlikely to be
helpful to the histopathologist in the
differentiation of Ewing's sarcoma from
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other small round-cell tumours, although
the use of immunofluorescence to indicate
the absence of type I collagen in tumour
cells could occasionally be used to differ-
entiate Ewing's tumours from osteogenic
sarcoma, and (ii) that Ewing's sarcoma is
unlikely to be of vascular endothelial
origin.
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